Phase I/II Study of A Novel MDM-2 Inhibitor (Apg-115-alrizomadlin) in P53 Wild Type Salivary Gland Cancers
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS(2024)
Key words
Salivary Gland Tumors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined